Consultant
National Cancer Centre, Singapore, Singapore
Dr Jolene Wong is a Consultant at the Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT). She graduated from the NUS Yong Loo Lin School of Medicine with consecutive Dean’s list awards between 2010 to 2014 and was subsequently selected to enter the Singhealth General Residency Programme, successfully completing her specialist training in 2019. She is a fellow of the Royal College of Surgeons, Edinburgh and holds a Master of Medicine (Surgery). Dr Wong is also a certified medical graduate of the United States Medical Licensing Examination (USMLE).
Dr Wong’s clinical area of expertise include peritoneal surface based malignancies, sarcomas, melanomas, and gastro-intestinal tumours. She has authored several scientific publications in regional and international journals and has delivered multiple scientific presentations at conferences worldwide. With a strong interest in clinical research, Dr Wong was awarded the Singapore General Hospital Academic Clinical Programme (SGH ACP) seed grant, the National Cancer Centre (NCC) Research Fund (NCCRF) and NCCS Cancer Fund (Research) in 2020 for her pilot clinical trial on Pressurised Intra-peritoneal Aerosolised Chemotherapy (PIPAC) in peritoneal metastases.
Beyond her clinical and research responsibilities, Dr Wong is a strong believer of volunteerism and philanthropy in medicine and spearheaded the development of the NUS-Neighbourhood health screening (NHS) programme, serving has the chairperson from 2011-2012. As an advisory committee member of the Cancer Education and Information Services aimed at providing personalised cancer education and treatment to cancer patients, she hopes that a synergy of good clinical research and a philanthropic spirit will serve as platforms to better the outcomes of oncological patients worldwide.
Dr Wong is also active and passionate about medical education and training, and is a clinician faculty member of the Singhealth General Surgery Residency Programme and a clinical tutor to students from NUS, Duke and NTU.